About

Francesco Chierigo is a urological surgeon and researcher whose work centers on advancing minimally invasive surgical techniques for kidney stones, bladder cancer, and prostate cancer. His major contributions include a landmark systematic review and meta-analysis comparing PCNL, laparoscopic, and robotic pyelolithotomy for large renal stones (24 citations), which provided crucial evidence for surgical decision-making. He has also conducted large-scale analyses of robotic-assisted versus open radical cystectomy outcomes (19 citations), demonstrating his expertise in health services research using national databases. Chierigo is at the forefront of evaluating novel robotic platforms, including the Hugo™ RAS system, with pioneering studies on retroperitoneal and transperitoneal partial nephrectomy (12 citations) and Retzius-sparing radical prostatectomy (7 citations). His work on intraoperative image-guidance and complication classification systems (7 citations) reflects a commitment to enhancing patient safety and surgical precision. With over 100 citations across his most-cited papers, Chierigo’s research is shaping the future of robotic urology, offering evidence-based insights that directly impact clinical practice and patient outcomes.

Research Focus

Key Achievements

6
H-Index
13
Papers
105
Total Citations
8
Avg Citations/Paper
🏆 Most Cited Paper
The fight between PCNL, laparoscopic and robotic pyelolithotomy: do we have a winner? A systematic review and meta-analysis
24 citations · 2022
📈 Most Prolific Year: 2024 (6 Papers)
🤝 Key Collaborators: 101
🏛 Institutions: University of Zurich, Université de Montréal, Ospedale Policlinico San Martino, Azienda Socio Sanitaria Territoriale Grande Ospedale Metropolitano Niguarda, Ospedale Maggiore, AOL (United States)

Top Papers

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago